Drugs like Ozempic and Wegovy are at the forefront of a health revolution. Originally used to treat diabetes, then obesity, these GLP-1 receptor agonists – drugs that mimic a hormone that reduces hunger – hold the promise of alleviating everything from cardiovascular disease to addiction and Alzheimer’s. Here, discover how the GLP-1 agonist boom is reshaping the world.